Skip to NavigationSkip to content

Pharmafile - Research and Development News

Drug overcomes close scrutiny of safety data
Torcetrapib cancellation leaves large hole in company's future revenues
Collaboration with Chi-Med builds pharma's R&D presence in China
Hopes that research could lead to immunisation breakthrough
Massive cost savings expected but merger will lead to loss of 800 US jobs
AstraZeneca must carry out second phase II trial on CytoFab
Novacea's Asentar shows impressive results in phase II trials
$100 milion investment signifies company's long-term commitment to Asian market
Updated contract should give patients earlier access to new drugs
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches